Weipeng Liu Selected Research

Weipeng Liu Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 01/2016
8	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 10/2010
3	Neoplasm Metastasis (Metastasis) 06/2021 - 01/2019
2	Margins of Excision 01/2022 - 01/2016
2	Uterine Cervical Dysplasia 01/2022 - 01/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2021
2	Nocturia 01/2021 - 01/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 08/2015 - 03/2015
1	Carcinoma (Carcinomatosis) 01/2022
1	Leukemia 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 01/2022
1	Breast Neoplasms (Breast Cancer) 06/2021
1	Hemorrhage 01/2021
1	Cataract (Cataracts) 07/2020
1	Infections 01/2020
1	Mental Disorders (Mental Disorder) 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Premature Birth (Birth, Premature) 12/2019
1	Perinatal Death 12/2019
1	Asphyxia (Suffocation) 12/2019
1	Ovarian Neoplasms (Ovarian Cancer) 07/2019
1	Intraoperative Complications 01/2019
1	Adenocarcinoma of Lung 08/2018
1	Intellectual Disability (Idiocy) 01/2018
1	Starvation 01/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2017
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2017
1	Adenoma (Adenomas) 01/2016
1	Atrophy 01/2015
1	Brain Injuries (Brain Injury) 01/2013
1	Vision Disorders (Hemeralopia) 01/2013
1	Cerebral Palsy (Spastic Diplegia) 01/2012

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2021
2	AntigensIBA 12/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2015
2	Jagged-1 ProteinIBA 07/2019 - 08/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Decitabine FDA Link 01/2022
1	Circular RNAIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	Histocompatibility Antigens Class IIBA 12/2021
1	transporter associated with antigen processing (TAP)IBA 12/2021
1	Peptides (Polypeptides)IBA 12/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 10/2021
1	Long Noncoding RNAIBA 06/2021
1	Bromodeoxyuridine (BrdU)IBA 06/2021
1	Untranslated RNA (Noncoding RNA)IBA 06/2021
1	Biological ProductsIBA 01/2020
1	Solifenacin Succinate FDA Link 01/2020
1	Levofloxacin (Levaquin)FDA Link 01/2020
1	SteroidsIBA 12/2019
1	Androgen Receptors (Androgen Receptor)IBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 08/2018
1	Cyanobacteria ToxinsIBA 01/2018
1	MicrocystinsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 08/2015
1	Vascular Endothelial Growth Factor CIBA 03/2015
1	Durapatite (Hydroxylapatite)IBA 10/2010
1	Caspase 2IBA 10/2010
1	Hormones (Hormone)IBA 10/2010
1	AndrogensIBA 10/2010
1	Pharmaceutical PreparationsIBA 10/2010
1	Oleic Acid (Oleate)IBA 10/2010
1	Docetaxel (Taxotere)FDA Link 10/2010

Therapy/Procedure

5	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 01/2020
3	Length of Stay 01/2022 - 01/2020
3	Nephrectomy 01/2022 - 01/2016
2	Operative Time 01/2022 - 01/2021
2	Therapeutics 01/2019 - 01/2017
2	Transplantation 01/2013 - 01/2012
1	Aftercare (After-Treatment) 01/2022
1	Cystectomy 10/2021
1	Drug Therapy (Chemotherapy) 10/2021
1	Catheters 01/2021
1	Refractive Surgical Procedures 07/2020
1	Cryosurgery 01/2019
1	Cell Transplantation 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Warm Ischemia 01/2016